tradingkey.logo
tradingkey.logo
Search

GE Healthcare Technologies Inc

GEHC
Add to Watchlist
71.940USD
+7.830+12.21%
Close 07-29 16:00ETQuotes delayed by 15 min
32.49BMarket Cap
17.17P/E TTM

GEHC Cash Flow Statement

You can access the annual and quarterly cash flow statements of GE Healthcare Technologies Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q1
FY2021Q4
FY2021Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
79.79%169.00M
15.60%289.00M
15.01%1.05B
-20.08%593.00M
178.99%94.00M
-40.33%250.00M
-13.05%913.00M
14.15%742.00M
-77.61%-119.00M
-10.47%419.00M
-1.22%1.05B
4.50%650.00M
---67.00M
0.00%468.00M
9763.64%1.06B
7.61%622.00M
--468.00M
---11.00M
--578.00M
Net income from continuing operations
14.80%574.00M
-30.10%411.00M
-18.43%602.00M
-5.11%464.00M
14.94%500.00M
51.55%588.00M
75.71%738.00M
28.01%489.00M
0.46%435.00M
1.31%388.00M
-25.93%420.00M
-22.67%382.00M
--433.00M
-4.73%383.00M
-1.56%567.00M
-4.26%494.00M
--402.00M
--576.00M
--516.00M
Operating gains losses
8.11%160.00M
12.50%153.00M
4.29%146.00M
3.50%148.00M
-0.67%148.00M
-8.11%136.00M
-2.78%140.00M
-6.54%143.00M
-4.49%149.00M
-5.73%148.00M
-8.28%144.00M
-4.38%153.00M
--156.00M
-1.26%157.00M
1.95%157.00M
3.23%160.00M
--159.00M
--154.00M
--155.00M
Other non-cash items
78.48%-34.00M
10.30%-148.00M
114.43%14.00M
10.78%113.00M
-777.78%-158.00M
24.31%-165.00M
-488.00%-97.00M
-75.36%102.00M
14.29%-18.00M
-489.19%-218.00M
-93.35%25.00M
51.65%414.00M
---21.00M
-136.63%-37.00M
19.75%376.00M
20.80%273.00M
--101.00M
--314.00M
--226.00M
Change in working capital
-74.10%-437.00M
51.05%-70.00M
52.56%328.00M
-204.82%-87.00M
50.88%-251.00M
-192.86%-143.00M
0.94%215.00M
156.85%83.00M
-80.57%-511.00M
81.18%154.00M
28.31%213.00M
-317.14%-146.00M
---283.00M
950.00%85.00M
118.67%166.00M
73.48%-35.00M
---10.00M
---889.00M
---132.00M
-Change in receivables
-4225.00%-165.00M
-28.57%95.00M
29.02%-159.00M
-268.12%-254.00M
107.02%4.00M
-33.50%133.00M
-873.91%-224.00M
-11.29%-69.00M
29.63%-57.00M
4100.00%200.00M
87.70%-23.00M
-1340.00%-62.00M
---81.00M
97.19%-5.00M
69.94%-187.00M
135.71%5.00M
---178.00M
---622.00M
---14.00M
-Change in inventory
-308.82%-139.00M
-11.04%-171.00M
-1.32%75.00M
29.27%-29.00M
40.35%-34.00M
-161.02%-154.00M
-61.22%76.00M
-147.13%-41.00M
-14.00%-57.00M
51.64%-59.00M
40.00%196.00M
191.58%87.00M
---50.00M
50.00%-122.00M
225.00%140.00M
44.44%-95.00M
---244.00M
---112.00M
---171.00M
-Change in other current liabilities
6.67%48.00M
151.47%35.00M
-23.08%80.00M
220.00%24.00M
600.00%45.00M
0.00%-68.00M
360.00%104.00M
83.05%-20.00M
64.00%-9.00M
-154.40%-68.00M
-139.60%-40.00M
-268.75%-118.00M
---25.00M
34.41%125.00M
380.56%101.00M
-18.52%-32.00M
--93.00M
---36.00M
---27.00M
Cash from non-recurring investing activities
Cash from operating activities
79.79%169.00M
15.60%289.00M
15.01%1.05B
-20.08%593.00M
178.99%94.00M
-40.33%250.00M
-13.05%913.00M
14.15%742.00M
-77.61%-119.00M
-10.47%419.00M
-1.22%1.05B
4.50%650.00M
---67.00M
0.00%468.00M
9763.64%1.06B
7.61%622.00M
--468.00M
---11.00M
--578.00M
Investing cash flow
Net cash from continuing investing activities
16.28%100.00M
17.11%178.00M
31.37%134.00M
22.22%110.00M
34.38%86.00M
4.83%152.00M
8.51%102.00M
12.50%90.00M
-7.25%64.00M
1.40%145.00M
23.68%94.00M
8.11%80.00M
--69.00M
47.42%143.00M
4.11%76.00M
32.14%74.00M
--97.00M
--73.00M
--56.00M
Capital expenditures
16.28%100.00M
17.11%178.00M
31.37%134.00M
22.22%110.00M
34.38%86.00M
4.83%152.00M
8.51%102.00M
12.50%90.00M
-8.57%64.00M
1.40%145.00M
22.08%94.00M
8.11%80.00M
--70.00M
43.00%143.00M
5.48%77.00M
23.33%74.00M
--100.00M
--73.00M
--60.00M
Net cash flow from disposal of fixed assets
16.28%100.00M
17.11%178.00M
31.37%134.00M
22.22%110.00M
34.38%86.00M
4.83%152.00M
8.51%102.00M
12.50%90.00M
-7.25%64.00M
1.40%145.00M
23.68%94.00M
8.11%80.00M
--69.00M
47.42%143.00M
5.56%76.00M
32.14%74.00M
--97.00M
--72.00M
--56.00M
Net cash flow from intangible asset transactions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
----
--1.00M
--0.00
Net cash flow from business transactions
140.00%4.00M
-753.90%-2.30B
-83.33%-99.00M
--0.00
96.14%-10.00M
---269.00M
---54.00M
--0.00
-1195.00%-259.00M
100.00%0.00
--0.00
--0.00
---20.00M
---127.00M
100.00%0.00
----
--0.00
---1.46B
--0.00
Net cash flow from investment products
25.00%-6.00M
35.00%-13.00M
-414.29%-36.00M
-63.64%-54.00M
---8.00M
---20.00M
---7.00M
---33.00M
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other investing activities
89.08%-13.00M
-135.29%-12.00M
100.00%0.00
214.29%16.00M
-357.69%-119.00M
179.07%34.00M
-1383.33%-77.00M
65.00%-14.00M
-620.00%-26.00M
-1175.00%-43.00M
131.58%6.00M
9.09%-40.00M
--5.00M
233.33%4.00M
-375.00%-19.00M
-57.14%-44.00M
---3.00M
---4.00M
---28.00M
Cash from non-current investing activities
Net cash flow from investing activities
48.43%-115.00M
-514.25%-2.50B
-12.08%-269.00M
-8.03%-148.00M
36.10%-223.00M
-116.49%-407.00M
-172.73%-240.00M
-14.17%-137.00M
-315.48%-349.00M
29.32%-188.00M
7.37%-88.00M
-1.69%-120.00M
---84.00M
-166.00%-266.00M
93.80%-95.00M
-40.48%-118.00M
---100.00M
---1.53B
---84.00M
Financing cash flow
Cash flow from continuous financing activities
-117.34%-236.00M
107.34%21.00M
77.06%-293.00M
-118.05%-165.00M
2487.72%1.36B
-86.93%-286.00M
-41.89%-1.28B
3908.33%914.00M
74.89%-57.00M
-122.73%-153.00M
-2332.43%-900.00M
95.25%-24.00M
---227.00M
260.24%673.00M
-102.64%-37.00M
13.68%-505.00M
---420.00M
--1.40B
---585.00M
Net cash flow from debt Issuance/repayment
-100.60%-9.00M
157.81%148.00M
79.20%-261.00M
-100.30%-3.00M
37325.00%1.49B
-69.54%-256.00M
-45.42%-1.25B
4835.00%987.00M
-33.33%-4.00M
-107.61%-151.00M
-110.53%-863.00M
300.00%20.00M
---3.00M
198400.00%1.99B
273300.00%8.20B
400.00%5.00M
--1.00M
---3.00M
--1.00M
Net cash flow from common stock issuance/repurchase
-100.00%-200.00M
---100.00M
--0.00
---100.00M
---100.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash dividend payments
0.00%16.00M
0.00%16.00M
14.29%16.00M
23.08%16.00M
14.29%16.00M
14.29%16.00M
7.69%14.00M
-7.14%13.00M
0.00%14.00M
--14.00M
--13.00M
--14.00M
--14.00M
----
----
----
----
----
----
Proceeds from stock option exercised by employees
-100.00%0.00
-50.00%10.00M
500.00%12.00M
-87.10%4.00M
--1.00M
--20.00M
--2.00M
--31.00M
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
15.38%-11.00M
38.24%-21.00M
-180.00%-28.00M
45.05%-50.00M
66.67%-13.00M
-383.33%-34.00M
58.33%-10.00M
-203.33%-91.00M
-4000.00%-39.00M
100.91%12.00M
99.71%-24.00M
94.12%-30.00M
--1.00M
-211.64%-1.31B
-686.40%-8.23B
12.97%-510.00M
---421.00M
--1.40B
---586.00M
Net cash from non-recurrent financing activities
Net cash from financing activities
-117.34%-236.00M
107.34%21.00M
77.06%-293.00M
-118.05%-165.00M
2487.72%1.36B
-86.93%-286.00M
-41.89%-1.28B
3908.33%914.00M
74.89%-57.00M
-122.73%-153.00M
-2332.43%-900.00M
95.25%-24.00M
---227.00M
260.24%673.00M
-102.64%-37.00M
13.68%-505.00M
---420.00M
--1.40B
---585.00M
Net cash flow
Beginning cash balance
----
56.07%4.51B
12.79%4.03B
86.62%3.77B
-3.43%2.48B
15.44%2.89B
47.60%3.57B
3.75%2.02B
9.90%2.56B
72.71%2.51B
380.16%2.42B
266.98%1.95B
--2.33B
158.65%1.45B
-29.41%504.00M
-35.13%530.00M
--561.00M
--714.00M
--817.00M
Current period cash flow changes
-113.96%-180.00M
-435.34%-2.23B
171.58%486.00M
-83.01%264.00M
335.65%1.29B
-805.08%-416.00M
-889.53%-679.00M
227.16%1.55B
-40.62%-547.00M
-93.32%59.00M
-90.92%86.00M
1926.92%475.00M
---389.00M
1705.45%883.00M
718.95%947.00M
74.76%-26.00M
---55.00M
---153.00M
---103.00M
Effect of exchange rate changes
-96.49%2.00M
-237.04%-37.00M
97.33%-2.00M
-141.03%-16.00M
359.09%57.00M
242.11%27.00M
-412.50%-75.00M
225.81%39.00M
-100.00%-22.00M
-337.50%-19.00M
-35.14%24.00M
-24.00%-31.00M
---11.00M
366.67%8.00M
436.36%37.00M
-108.33%-25.00M
---3.00M
---11.00M
---12.00M
Ending cash balance
-44.03%2.11B
-7.59%2.29B
56.07%4.51B
12.82%4.03B
86.62%3.77B
-3.47%2.48B
15.44%2.89B
47.60%3.57B
3.75%2.02B
9.90%2.56B
72.71%2.51B
380.16%2.42B
--1.95B
361.26%2.33B
158.65%1.45B
-29.41%504.00M
--506.00M
--561.00M
--714.00M
Free cash flow
762.50%69.00M
13.27%111.00M
12.95%916.00M
-25.92%483.00M
104.37%8.00M
-64.23%98.00M
-15.17%811.00M
14.39%652.00M
-33.58%-183.00M
-15.69%274.00M
-3.04%956.00M
4.01%570.00M
---137.00M
-11.68%325.00M
1273.81%986.00M
5.79%548.00M
--368.00M
---84.00M
--518.00M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did GE Healthcare Technologies Inc Generate?

GE Healthcare Technologies Inc generated 1.99B in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did GE Healthcare Technologies Inc's Operating Cash Flow Change Year Over Year?

GE Healthcare Technologies Inc's operating cash flow increased by 1.64% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does GE Healthcare Technologies Inc Spend on Capital Expenditures?

GE Healthcare Technologies Inc spent 482.00M on capital expenditures in the most recent quarter。

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has GE Healthcare Technologies Inc's Financing Cash Flow Changed?

GE Healthcare Technologies Inc used 617.00M in financing activities in the latest quarter.

What is free cash flow and why does it matter for GEHC?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was GE Healthcare Technologies Inc’s free cash flow in the latest quarter?

Free cash flow was 1.50B reflecting a -3.15% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.